This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2019-2020.
Location History:
- Fontenay aux Roses, FR (2019)
- Paris, FR (2020)
Company Filing History:
Years Active: 2019-2020
Title: Romain Grall: Innovator in Nanoparticle-Assisted Radiotherapy
Introduction
Romain Grall is a notable inventor based in Paris, France. He has made significant contributions to the field of radiotherapy through his innovative inventions. With a total of 2 patents, Grall is recognized for his work in utilizing nanotechnology for therapeutic purposes.
Latest Patents
Grall's latest patents include an "Apparatus for performing nanoparticle-assisted external beam radiotherapy and method carried out using said apparatus." This invention features an X-ray spectrometer with an optical axis, an X-ray filter, and a mobile holding structure. The apparatus allows for the positioning of a patient body part in a target region while switching between relative positions of the X-ray filter and spectrometer. The X-ray beam emitted from the source crosses the filter before reaching the target point, forming an angle different from 0° and 180° with the optical axis.
Another significant patent is the "Use of nanodiamonds for generating free radicals for therapeutic purposes under radiation." This invention focuses on the use of nanodiamonds as drugs that generate free radicals, particularly for tumor treatment. The process involves generating free radicals on the surface of nanodiamonds when exposed to radiation, enhancing their effectiveness by complexing them with radiosensitizing agents.
Career Highlights
Romain Grall is associated with the Commissariat à l'Énergie Atomique et aux Énergies Alternatives, where he continues to advance his research and innovations. His work has the potential to revolutionize cancer treatment by improving the efficacy of radiotherapy.
Collaborations
Grall collaborates with esteemed colleagues such as Sylvie Chevillard and Tristan Petit, contributing to a dynamic research environment that fosters innovation.
Conclusion
Romain Grall's contributions to nanoparticle-assisted radiotherapy exemplify the intersection of technology and medicine. His inventions hold promise for enhancing cancer treatment methodologies and improving patient outcomes.